Literature DB >> 15944126

Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism.

Weichun Lin1, Bertha Dominguez, Jiefei Yang, Prafulla Aryal, Eugene P Brandon, Fred H Gage, Kuo-Fen Lee.   

Abstract

Synapse formation requires interactions between pre- and postsynaptic cells to establish the connection of a presynaptic nerve terminal with the neurotransmitter receptor-rich postsynaptic apparatus. At developing vertebrate neuromuscular junctions, acetylcholine receptor (AChR) clusters of nascent postsynaptic apparatus are not apposed by presynaptic nerve terminals. Two opposing activities subsequently promote the formation of synapses: positive signals stabilize the innervated AChR clusters, whereas negative signals disperse those that are not innervated. Although the nerve-derived protein agrin has been suggested to be a positive signal, the negative signals remain elusive. Here, we show that cyclin-dependent kinase 5 (Cdk5) is activated by ACh agonists and is required for the ACh agonist-induced dispersion of the AChR clusters that have not been stabilized by agrin. Genetic elimination of Cdk5 or blocking ACh production prevents the dispersion of AChR clusters in agrin mutants. Therefore, we propose that ACh negatively regulates neuromuscular synapse formation through a Cdk5-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944126     DOI: 10.1016/j.neuron.2005.04.002

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  94 in total

1.  The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.

Authors:  Tohru Tezuka; Akane Inoue; Taisuke Hoshi; Scott D Weatherbee; Robert W Burgess; Ryo Ueta; Yuji Yamanashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  Molecular mechanism of active zone organization at vertebrate neuromuscular junctions.

Authors:  Hiroshi Nishimune
Journal:  Mol Neurobiol       Date:  2011-12-02       Impact factor: 5.590

3.  CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation.

Authors:  Jun-Ping Bai; Alexei Surguchev; Powrnima Joshi; Liza Gross; Dhasakumar Navaratnam
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-16       Impact factor: 4.249

Review 4.  Wnt signaling in neuromuscular junction development.

Authors:  Kate Koles; Vivian Budnik
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06       Impact factor: 10.005

5.  Time lapse in vivo visualization of developmental stabilization of synaptic receptors at neuromuscular junctions.

Authors:  Pessah Yampolsky; Pier Giorgio Pacifici; Lukas Lomb; Günter Giese; Rüdiger Rudolf; Ira V Röder; Veit Witzemann
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

6.  Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction.

Authors:  Jia Wang; Xiu-Qing Fu; Wen-Liang Lei; Tong Wang; Ai-Li Sheng; Zhen-Ge Luo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 7.  Moving and positioning the nucleus in skeletal muscle - one step at a time.

Authors:  Bruno Cadot; Vincent Gache; Edgar R Gomes
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

Review 8.  Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.

Authors:  Pedro Cisternas; Juan P Henriquez; Enrique Brandan; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-09-07       Impact factor: 5.590

Review 9.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 10.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.